Lymecycline, a semi-synthetic tetracycline antibiotic, continues to be a valuable option for treating a variety of bacterial infections, particularly in dermatology. Its well-defined pharmacological properties, favorable safety profile, and ease of use make it a versatile antibiotic in both primary and specialty care settings. However, with the i